Aug 23, 2022 / 12:30PM GMT
Operator
Ladies and gentlemen, and welcome to the ADial Pharmaceuticals business update conference call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, David Waldman of Investor Relations. Sir, the floor is yours.
David Waldman - Adial Pharmaceuticals Inc. - IR
Good morning and thank you for joining ADial Pharmaceuticals business update conference call. On the call with us today are Kevin Schuyler, ADial's Chairman, and the Company's new CEO, Cary Claiborne.
Before we get started, we'd like to remind everyone that this call contains certain forward-looking statements within the meaning of the US federal securities laws. Such statements are based upon various facts and derived utilizing numerous important assumptions, and is subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements.
Statements preceded by followed
Adial Pharmaceuticals Inc Business Update Call Transcript
Aug 23, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers